Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Dividend Declaration

19 Sep 2014 07:00

RNS Number : 0817S
BrainJuicer Group PLC
19 September 2014
 



 

 

BrainJuicer Group PLC

 ("BrainJuicer" and the "Company")

 

Dividend Declaration

 

The Company announces that it will pay an interim dividend of 1.0 pence per share (totalling £126,000) in respect of the year ending 31 December 2014, up 11% from 0.9 pence per share (totalling £113,000) in 2013. 

 

The interim dividend will be paid on 12 November 2014 to shareholders on the register as of 3 October 2014, and the shares will become ex dividend on 1 October 2014. Going forward, the Company expects to maintain dividend growth broadly in line with earnings per share.

 

The Company can be found at www.brainjuicer.com.

 

 

- Ends -

 

 

For further information, please contact:

 

BrainJuicer Group PLC

John Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer www.brainjuicer.com

 

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor Tel: +44 (0)20 7523 8000

www.canaccordgenuity.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DIVZMGMLNRZGDZM
Date   Source Headline
5th Jun 20077:03 amRNSProgress - Predictive Markets
25th May 200712:45 pmRNSResult of AGM
30th Apr 20077:01 amRNSTotal Voting Rights
25th Apr 20075:41 pmRNSIssue of Equity
12th Apr 20077:01 amRNSPreliminary Results
5th Apr 20077:01 amRNSNotice of Results
19th Jan 20075:10 pmRNSDirector/PDMR Shareholding
15th Dec 200611:13 amRNSTotal Voting Rights
5th Dec 20068:00 amRNSFirst Day of Dealings on AiM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.